Rousselot® Biomedical Announces the Launch of Quali-Pure HGP 2000
Irving, United States, May 4 2022 / Sciad Newswire / Rousselot®,
Darling Ingredients’ health brand and the global leader of
collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new
endotoxin-controlled, pharmaceutical-grade gelatin specifically designed
for vaccines and wound healing applications. As the latest addition to
Rousselot Biomedical’s rapidly expanding product offering, this new
non-gelling hydrolyzed gelatin further extends the scope of biomedical
applications covered by Rousselot products.
More info >> |
